Navigation Links
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
Date:5/9/2013

ll

76,50176,501Other assets

9,2529,443Total assets

$
447,901$
497,790LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
4,218$
2,863Accrued compensation

8,9528,773Accrued expenses

6,9468,008Accrued clinical trial expenses

24,03217,500Deferred revenue, current portion

23,23921,896Interest payable

3,1677,083Other current liabilities

12,66712,414Total current liabilities

83,22178,537Senior secured notes

125,000125,000Capital lease obligations, less current portion

10,76611,607Liability related to sale of future royalties, less current portion 

122,416128,266Deferred revenue, less current portion

97,91896,551Deferred gain

2,1852,404Other long-term liabilities

9,0158,407Total liabilities

450,521450,772Commitments and contingenciesStockholders' equity:Preferred stock

--Common stock

1111Capital in excess of par value

1,623,2071,617,744Accumulated other comprehensive loss

(395)(357)Accumulated deficit

(1,625,443)(1,570,380)Total stockholders' (deficit) equity

(2,620)47,018Total liabilities and stockholders' equity

$
447,901$
497,790 

(1) The consolidated balance sheet at December 31, 2012 has been derived from the audited financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles in the United States for complete financial statements.  NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share information)(Unaudited)Three Months Ended

March 31, 20132012Revenue:Product sales 

$  11,810$
,945Royalty revenues 

3253,177Non-cash royalty revenue related to sale of future royalties

4,393
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
4. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
5. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
6. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
8. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
9. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
10. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  Today, the National Mobility Equipment ... 2015 National Mobility Awareness Month Local Heroes Contest on ... online entries that received 1.3 million votes. The sponsors ... Toyota Mobility , and Valley Honda Dealers ... and Vantage Mobility International (VMI) and ...
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... Minn. , June 30, 2015  EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering  of 40,229,886 units. Each ... of a Series A warrant to purchase one share ... warrant to purchase one share of common stock, at ...
Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
(Date:6/30/2015)... ... 30, 2015 , ... When it comes to volunteering abroad, not many people ... will be too high. However, there are affordable programs to be had such as ... minimal cost. One such volunteer named Uzma Aishah, a student at the International Medical ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... and repair companies in San Diego. Bill Howe offers all employees ample opportunity ... several organizations, but most notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). ...
(Date:6/30/2015)... ... 2015 , ... The Glenholme School graduated seventeen ... , The independent, coeducational, special needs boarding school began its eleventh commencement ... Center for the Arts. Along the way, the soon-to-be-graduates paused to observe the ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lecrae is quickly developing into one ... Rolling Stone and The New York Times to Billboard Magazine and Variety, among others. ... of the many reasons why so many people are taking notice. , “We are ...
(Date:6/30/2015)... ... June 30, 2015 , ... The ... 28-31, 2015 at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and ... year, this premiere event for psychiatric-mental health nursing draws more than 1,500 health ...
Breaking Medicine News(10 mins):Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:The Glenholme School Graduates Its Class of 2015 2Health News:The Glenholme School Graduates Its Class of 2015 3Health News:The Glenholme School Graduates Its Class of 2015 4Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3
... RICHMOND, Va., July 27 Insmed Inc. (Nasdaq: ... the Company will cease the supply of IPLEX((TM)) to any new ... trials with IPLEX((TM)) at this time. The Company has determined ... treatment of existing patients. , , ...
... , , ... will hold three (3) rallies this week to urge Congress to pass ... is being stalled because of partisanship and political infighting, the campaign seeks ... suffer daily because of escalating health care costs and sub-standard medical care. ...
... , , , ... (Nasdaq: SNSS ) today announced that Helen S. Kim ... Ms. Kim is a designee of New Enterprise Associates, which purchased ... of the company,s recent private placement. , , ...
... Emerging Therapies to Treat Metastatic Hormone-Refractory Prostate Cancer Will ... New Report from Decision Resources , , ... of the world,s leading research and advisory firms for pharmaceutical ... prostate cancer drug market though 2018 will be driven principally ...
... DENVER, July 27 Because nearly everyone struggles with medical bills, medical ... some tips on how you can best use and pay for your ... most respected companies of its type. These tips are from Andrew Graham, ... Your doctor will be more helpful to you if you are ...
... SynCare, LLC(R), an innovator in disease and case management, has been ... n a C o mp a n ... h . The 50 Companies to Watch program, created and managed by ... Small Business Development Center network and Purdue University. , , The ...
Cached Medicine News:Health News:Insmed Provides Update on Supply of IPLEX(TM) 2Health News:Insmed Provides Update on Supply of IPLEX(TM) 3Health News:Delaying Health Care Reform is U-N-A-C-C-E-P-T-A-B-L-E! 2Health News:Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors 2Health News:Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018 2Health News:Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018 3Health News:What the Medical Biller Knows (That You Should Know) 2Health News:SynCare, LLC Honored as Indiana Company to Watch 2